COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00164138
Recruitment Status : Completed
First Posted : September 14, 2005
Last Update Posted : November 28, 2013
University of Melbourne
Information provided by (Responsible Party):
Bayside Health

Brief Summary:
Women with chronic lung disease characterised by chronic cough report urinary incontinence. Recently there have been reports of increased urinary incontinence in girls and women with cystic fibrosis. While coughing is a known risk factor for stress incontinence, other risk factors and causes are poorly understood in this population. Treatment of incontinence for patients with chronic lung disease is also poorly addressed, adding to the burden of disease for women with chronic lung disease, carers and the health system. This project will estimate the prevalence of women with CF and COPD compared to healthy age matched controls and will evaluate the effect of a specific treatment and management program for these patients. The results will be disseminated to respiratory health professionals. We hypothesise that women with chronic cough will have a higher incidence of urinary incontinence than healthy controls and that a specific treatment program will result in alleviation of the problems and improved quality of life.

Condition or disease Intervention/treatment Phase
Cystic Fibrosis Chronic Obstructive Pulmonary Disease (COPD) Procedure: Pelvic floor training group Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 99 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Development of an Intervention and and Education Program for Adult Women With Urinary Incontinence and Chronic Lung Disease Including Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD)
Study Start Date : December 2001
Actual Primary Completion Date : June 2004
Actual Study Completion Date : June 2004

Arm Intervention/treatment
Experimental: Pelvic Floor Training Group
Pelvic floor training, biofeedback.
Procedure: Pelvic floor training group
pelvic floor training, electrotherapy, bladder retraining.

Primary Outcome Measures :
  1. Symptom measures:
  2. 3-day frequency volume chart,
  3. 24 hour pad weigh test,
  4. accident diary,
  5. quality of life using King's Health Questionnaire.
  6. pelvic floor muscle function:
  7. Trans-abdominal diagnostic ultra-sound
  8. EMG study of the pelvic floor muscles

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Women with CF and COPD

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00164138

Layout table for location information
Australia, Victoria
The Alfred Hospital
Melbourne, Victoria, Australia, 3004
School of Physiotherapy, The University of Melbourne
Melbourne, Victoria, Australia, 3052
Sponsors and Collaborators
Bayside Health
University of Melbourne
Layout table for investigator information
Principal Investigator: Brenda M Button, DPhty, PhD The Alfred
Study Director: John W Wilson, MBBS, PhD The Alfred
Layout table for additonal information
Responsible Party: Bayside Health Identifier: NCT00164138    
Other Study ID Numbers: 108/01
Dept. of Health and Aged Care
First Posted: September 14, 2005    Key Record Dates
Last Update Posted: November 28, 2013
Last Verified: September 2005
Keywords provided by Bayside Health:
pelvic floor muscle function
forced expirations
lung disease
Additional relevant MeSH terms:
Layout table for MeSH terms
Cystic Fibrosis
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Urinary Incontinence
Pathologic Processes
Respiratory Tract Diseases
Pancreatic Diseases
Digestive System Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Urination Disorders
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Behavioral Symptoms
Elimination Disorders
Mental Disorders